Tehran University of Medical Sciences: Diabetes Mellitus, Type 2 trials

The registry lists 15 Diabetes Mellitus, Type 2 studies with Tehran University of Medical Sciences as lead sponsor. 1 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 2Phase 4 3No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Effects of Fenugreek Extract (Fenobet) on Metabolic SyndromeNot yet recruitingNCT06114134Not applicable
• EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes MellitusCompletedNCT03258840Not applicable
• Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus SulfonylureaCompletedNCT03125694Phase 3
• The Assessment of the Effect of Vitamin D Supplementation on Inflammatory and Endothelial Factors in the Patients With Type 2 Diabetes .Status unknownNCT03008057Phase 2/3
• Effects of Ginger Supplementation on NF-KB in Peripheral Blood Mononuclear Cells in Type 2 Diabetes MellitusCompletedNCT02666807Not applicable
• The Effect of n-3 Fatty Acid Supplementation on Serum Levels, and Gene Expression of type2 Diabetes PatientStatus unknownNCT02261545Phase 4
• Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes PatientsCompletedNCT02027103Not applicable
• Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes PatientsCompletedNCT01963663Not applicable
• Biphasic Insulin Aspart Versus NPH Plus Regular Human Insulin in Type 2 Diabetic PatientsCompletedNCT01889095Phase 4
• Cost Effectiveness of Glargine Insulin Versus NPH InsulinCompletedNCT01832935Phase 4
• Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood PressureCompletedNCT01667614Phase 2
• Comparison of Metformin and Pioglitazone Effects on Adipokines Concentrations in Newly Diagnosed Type 2 Diabetes PatientsCompletedNCT01593371Not applicable
• A Community Pharmacy-based Program to Improve Management of DiabetesCompletedNCT01525992Not applicable
• Metformin Effects on Oxidative Stress Parameters in Newly Diagnosed Type 2 Diabetes PatientsCompletedNCT01521624Not applicable
• Effectiveness of the Farsi Diabetes Self-management Education (FDSME) Program for People With Type 2 DiabetesCompletedNCT01050803Not applicable